CIK 0001674416 · Large accelerated filer
CRISPR Therapeutics AG
Sign in to watch- Ticker
- CRSP
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- Switzerland
- Entity type
- operating
- EIN
- 473173478
- Phone
- 6173154600
- Business address
- BAARERSTRASSE 14, ZUG, Switzerland
- Former names
- CRISPR Therapeutics AG
- 10-Q Report Quarterly Report
- 8-K Event Results of operations
- 4 Planned sale Chief Executive Officer sold 25,000 shares at an average $50.67 ($1,266,638)
- ARS Other Annual Report to Security Holders
- DEFA14A Proxy Proxy Materials
- DEF 14A Proxy Proxy Statement
- 144 Insider Sale of Securities
- SC 13G/A Stake Amended Statement of Ownership
- PRE 14A Proxy Proxy Statement (Preliminary)
- 8-K Event Regulation FD disclosure · Other events
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $44.46 ($1,111,504)
- 8-K Event Executive or director change
- 8-K Event Material agreement · Regulation FD disclosure
- 4 Derivatives Options or other derivatives
- 4 Shares withheld for taxes Chief Executive Officer gave up 9,444 shares (to pay taxes)
- 4 Shares withheld for taxes General Counsel and Secretary gave up 2,305 shares (to pay taxes)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 8-K Event Executive or director change
- 4 Open-market sale Chief Executive Officer sold 25,000 shares at an average $48.25 ($1,206,243)
Page 14 of 45 · 883 filings